Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

Nufarm (ASX:NUF) reveals FY20 guidance and impairments

Nufarm Limited (ASX:NUF) has announced an earnings estimate for its FY20 and also revealed impairments. The Nufarm share price is on watch. 

Nufarm Limited (ASX: NUF) has announced an earnings estimate for its FY20 and also revealed impairments. The Nufarm share price is on watch.

Nufarm is an agricultural chemical company with global operations.

Source: Rask Media NUF 1-year share price chart.

Nufarm’s FY20 guidance

Nufarm announced that it expects to recognise a major impairment in the FY20 result. It expects that the value of its European assets will be impaired by approximately $215 million, comprising a $190 million impairment of intangible assets and a dercognition of tax assets of around $25 million.

This is due to the recent operating performance and lower outlook for future earnings based on margin pressure because of higher manufacturing costs and increased competition.

Nufarm CEO Greg Hunt said: “We believe the European business has reached an earnings trough in FY20, however it is appropriate to take this step to revise the carrying value of the assets.

We have a comprehensive improvement program underway in Europe to grow revenues, reduce our cost to serve and lift margins. We expect this program, combined with an anticipated easing in raw material costs and improved weather conditions would be the major drivers of improved profitability in the European business in FY21.”

In terms of financial guidance, Nufarm expects underlying EBITDA to be between $290 million to $300 million (click here to learn what EBITDA means). After the sale of its South American businesses, underlying EBITDA from continuing operations is expected to be between $230 million to $240 million.

The drought breaking in Australia has helped, with second half underlying EBITDA doubling in ANZ with a good outlook for summer. EBITDA is also up in North America, particularly Canada. Asia is also benefiting from improved weather. However, Europe has declined heavily due to hot, dry weather.

Summary

I’m not sure if the Nufarm share price is a buy, I don’t know enough about the company. But it seems like a variable business, which can be tough. I prefer consistently growing ASX growth shares like Pushpay Holdings Ltd (ASX: PPH).

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

At the time of publishing, the author of this article does not have a financial or commercial interest in any of the companies mentioned.
Skip to content